Your browser doesn't support javascript.
loading
Outlier Expression of Isoforms by Targeted or Total RNA Sequencing Identifies Clinically Significant Genomic Variants in Hematolymphoid Tumors.
Tsai, Harrison K; Gogakos, Tasos; Lip, Va; Tsai, Jonathan M; Li, Yen-Der; Fisch, Adam S; Weiss, Jonathan; Yang, Weiping; Grimmett, Leslie; DiToro, Daniel; Schaefer, Eva J; Lindsley, R Coleman; Tran, Thai Hoa; Caron, Maxime; Langlois, Sylvie; Sinnett, Daniel; Pikman, Yana; Nardi, Valentina; Kim, Annette S; Silverman, Lewis B; Harris, Marian H.
Afiliación
  • Tsai HK; Department of Pathology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. Electronic address: harrison.tsai@childrens.harvard.edu.
  • Gogakos T; Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
  • Lip V; Department of Pathology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts.
  • Tsai JM; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
  • Li YD; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
  • Fisch AS; Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
  • Weiss J; Department of Pathology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts.
  • Yang W; Department of Pathology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts.
  • Grimmett L; Department of Pathology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts.
  • DiToro D; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
  • Schaefer EJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
  • Lindsley RC; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
  • Tran TH; Division of Pediatric Hematology-Oncology, Centre Hospitalier Universitaire Sainte-Justine, Montreal, Quebec, Canada; Immune Diseases and Cancers Axis, Centre Hospitalier Universitaire Sainte-Justine, Montreal, Quebec, Canada.
  • Caron M; Immune Diseases and Cancers Axis, Centre Hospitalier Universitaire Sainte-Justine, Montreal, Quebec, Canada.
  • Langlois S; Immune Diseases and Cancers Axis, Centre Hospitalier Universitaire Sainte-Justine, Montreal, Quebec, Canada.
  • Sinnett D; Division of Pediatric Hematology-Oncology, Centre Hospitalier Universitaire Sainte-Justine, Montreal, Quebec, Canada; Immune Diseases and Cancers Axis, Centre Hospitalier Universitaire Sainte-Justine, Montreal, Quebec, Canada.
  • Pikman Y; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts; Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts.
  • Nardi V; Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
  • Kim AS; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
  • Silverman LB; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts; Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts.
  • Harris MH; Department of Pathology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts. Electronic address: marian.harris@childrens.harvard.edu.
J Mol Diagn ; 25(9): 665-681, 2023 09.
Article en En | MEDLINE | ID: mdl-37419244
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Leucemia-Linfoma Linfoblástico de Células Precursoras B / Neoplasias Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: J Mol Diagn Asunto de la revista: BIOLOGIA MOLECULAR Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Leucemia-Linfoma Linfoblástico de Células Precursoras B / Neoplasias Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: J Mol Diagn Asunto de la revista: BIOLOGIA MOLECULAR Año: 2023 Tipo del documento: Article